NUCALA (mepolizumab) Patient Assistance Program
Don’t let the high cost of brand specialty asthma biologics stand between you and the treatment you need. We help eligible patients access Nucala (mepolizumab) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Nucala (mepolizumab) is FDA-approved for severe eosinophilic asthma in patients 6 years and older, eosinophilic granulomatosis with polyangiitis (EGPA) in adults, hypereosinophilic syndrome (HES), and chronic rhinosinusitis with nasal polyps. It is given as a subcutaneous injection every 4 weeks.
- Without assistance, the average retail price runs approximately $4,000–$4,500 per monthly dose, with annual costs commonly $50,000+.
- Through AffordMyPrescriptions, qualifying patients can access Nucala for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- There is no biosimilar version of Nucala available in the U.S. as of 2026. Other anti-IL-5 biologics (Cinqair, Fasenra) are available for severe eosinophilic asthma.
What Is Nucala Prescription Assistance Program?
The Nucala Prescription Assistance Program is a manufacturer-sponsored initiative that provides Nucala at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for severe asthma and other eosinophil-driven conditions in patients who are uninsured or underinsured, as well as Medicare Part D beneficiaries.
Navigating the program on your own means dealing with eligibility verification, pulmonology/allergy/rheumatology coordination, eosinophil count documentation, prior-authorization documentation, specialty pharmacy logistics, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification — so you focus on your health, not paperwork.
Pharmacy Price Comparison
- Without assistance, Nucala costs roughly $4,000–$4,500 per monthly dose. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$4,400.00 | Save ~$4,330/dose |
| CVS Pharmacy | ~$4,500.00 | Save ~$4,430/dose |
| Walmart | ~$4,200.00 | Save ~$4,130/dose |
| Costco | ~$4,100.00 | Save ~$4,030/dose |
| Specialty Pharmacy | ~$4,200.00 | Save ~$4,130/dose |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Nucala Prescription Program?
The Patient Assistance Program is free to apply for and provides Nucala at no medication cost if approved. But the process involves detailed applications, prescriber coordination, eosinophil count documentation, prior-authorization documentation, specialty pharmacy logistics, and ongoing renewal management. Our $69.95/month service covers full advocacy.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Nucala:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $4,000–$4,500 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Nucala assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Nucala Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Nucala:
Nucala (mepolizumab) is a biologic medicine in the anti-interleukin-5 (IL-5) class used to treat several eosinophil-driven inflammatory conditions — severe eosinophilic asthma in patients 6 and older, eosinophilic granulomatosis with polyangiitis (EGPA) in adults, hypereosinophilic syndrome (HES), and chronic rhinosinusitis with nasal polyps. It is given as a subcutaneous injection every 4 weeks.
How Nucala Works:
Nucala is a monoclonal antibody that targets Interleukin-5 (IL-5), the primary regulator of eosinophil production and survival. In certain types of asthma and inflammatory conditions, overactive eosinophils accumulate in tissues and cause damage. By blocking IL-5 from connecting to its receptors, Nucala reduces eosinophil counts and dampens inflammation, leading to fewer asthma exacerbations and a reduced need for systemic corticosteroids.
Form and use:
This medication is administered as a subcutaneous injection once every four weeks. It is available in a 100 mg prefilled syringe or autoinjector for adults, while pediatric patients aged 6–11 receive a lower 40 mg dose. After receiving proper training, some patients may self-administer the injection at home. Nucala functions as a long-term controller and should never be used to treat acute asthma symptoms.
Generic availability:
As of 2026, there is no FDA-approved biosimilar version of Nucala available in the United States. Other biologic options that target the IL-5 pathway include Cinqair (administered intravenously) and Fasenra (a subcutaneous injection). The choice between these treatments depends on a patient’s specific diagnosis, treatment history, and preference for how frequently they receive their medication.
Warnings:
Nucala carries warnings for hypersensitivity reactions, including anaphylaxis, and the potential reactivation of the herpes zoster (shingles) virus. Patients with parasitic infections should be treated before starting therapy, and live vaccines should be avoided while using the medication. It is essential to remember that Nucala is not a rescue medication and will not work for acute asthma attacks or status asthmaticus.
FAQ (Frequently Asked Questions)
How Much Does Nucala Cost Without Insurance?
The average retail price runs approximately $4,000–$4,500 per monthly dose. Annual costs commonly reach $50,000+. Through AffordMyPrescriptions, qualifying patients receive Nucala at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
How Is Nucala Different From Other Asthma Biologics?
Nucala targets IL-5, a key cytokine driving eosinophilic inflammation. Other anti-IL-5 biologics include reslizumab (Cinqair, IV monthly) and benralizumab (Fasenra, SC every 4 weeks initially, then every 8 weeks). Other severe asthma biologics target different mechanisms — anti-IgE (Xolair), anti-IL-4Rα (Dupixent), and anti-TSLP (Tezspire). Whether Nucala or a different biologic is a better fit depends on your phenotype (eosinophilic vs. allergic vs. mixed), eosinophil count, and IgE level.
Do I Need Eosinophil Testing Before Starting Nucala?
Yes, for severe eosinophilic asthma. Patients are typically required to have eosinophil counts ≥150 cells/μL at initiation (or ≥300 cells/μL within the past 12 months) to qualify for Nucala in severe eosinophilic asthma. Other indications (EGPA, HES, nasal polyps) have different eligibility criteria.
Can I Self-Administer Nucala At Home?
Yes, for many patients. Nucala is available as a prefilled autoinjector or syringe for self-administration after training by a healthcare provider. Initial doses are typically given in a healthcare setting, but ongoing every-4-week dosing can usually be done at home.
Can I Get Nucala Through The PAP If I Have Medicare?
Yes. Medicare Part D beneficiaries can typically qualify for Nucala Patient Assistance, especially if you face specialty-tier copays you cannot afford. The manufacturer’s commercial copay savings program is reserved for commercially insured patients only — but the underlying PAP supports Medicare patients who meet income criteria.
What If My Application Is Denied?
If your initial application is denied, we explore alternatives — the manufacturer’s copay savings program if you have commercial insurance, independent foundations such as the Asthma and Allergy Foundation of America, American Lung Association, PAN Foundation, or HealthWell Foundation, or asking your prescriber whether a different anti-IL-5 biologic (Fasenra, Cinqair) or another severe asthma biologic on a more accessible assistance pathway would be appropriate. If we cannot find a path, you will not be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Nucala, our team may be able to help you access assistance programs designed to make brand specialty severe asthma biologics affordable. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.